Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bitter Taste Receptors in the GI Tract: Effects on Motility and Intake
NCT02759926Unknown
- Sponsor
- UZ Leuven
- Start
- Aug 2011
- Primary completion
- Nov 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01
Overview
Randomised trial of denatonium benzoate and quinine in obesity (6 arms), sponsored by UZ Leuven. Primary endpoint: Change in gastrointestinal motility. Status: unknown.
02
Drugs
denatonium benzoatequinine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02759926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02759926.